- Mutation Status Drives PARP Inhibitor Investigation and Treatment in mCRPC.
- Wahner A.
- OncLive. 2023 Feb 1.
- Commentary
- Free Full Text
- Dr. King on Delays in Access to Germline Testing in Pancreatic Cancer.
- King D.
- OncLive. OncLive TV. 2023 Jan 31.
- Conference report
- Free video
- The Role of PARP Inhibitors in Non-BRCA Mutated Breast Cancer.
- Ballinger TJ.
- Medscape Oncology. Decision Point. 2023 Jan 13.
- Review
- Free Full Text